Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Individual needs in oral contraception.

E Weisberg

    Australian Family Physician
    |February 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Women respond differently to oral contraceptives. Use the lowest effective dose and allow three months before changing formulations to ensure informed decisions about reproductive health.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL.

    British journal of cancer·2019
    Same author

    The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression.

    Leukemia·2012
    Same author

    Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors.

    Leukemia·2012
    Same author

    Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib.

    Leukemia·2011
    Same author

    The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity.

    Leukemia·2011
    Same author

    Smac mimetics: implications for enhancement of targeted therapies in leukemia.

    Leukemia·2010
    Same journal

    Occupational violence and staff safety in general practice.

    Australian family physician·2018
    Same journal

    You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

    Australian family physician·2018
    Same journal

    Understanding the decision to commence a dose administration aid.

    Australian family physician·2018
    Same journal

    Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

    Australian family physician·2018
    Same journal

    A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

    Australian family physician·2018
    Same journal

    The Australian Mid-West Coastal Marine Wound Infections Study.

    Australian family physician·2018
    See all related articles

    Area of Science:

    • Reproductive Health
    • Pharmacology

    Background:

    • Individual responses to oral contraceptive pills (OCPs) vary significantly.
    • Optimizing OCP selection requires understanding patient-specific factors.

    Purpose of the Study:

    • To emphasize personalized approaches in oral contraceptive therapy.
    • To guide clinicians on appropriate OCP management strategies.

    Main Methods:

    • Review of existing literature on oral contraceptive efficacy and patient response.
    • Analysis of factors influencing individual variability in OCP effectiveness.

    Main Results:

    • No single OCP formulation is universally effective for all women.
    • A minimum three-month trial period is recommended before considering formulation changes.

    Related Experiment Videos

  • Informed decision-making regarding contraceptive methods is crucial.

    • Conclusions:

    • Personalized medicine is key to effective oral contraception.
    • Clinicians should prioritize patient education on OCP risks and benefits.
    • Accurate information can mitigate the impact of biased media reporting on OCP safety.